Compare AURA & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AURA | PCT |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 631.6M | 556.5M |
| IPO Year | 2021 | 2020 |
| Metric | AURA | PCT |
|---|---|---|
| Price | $7.11 | $1.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $16.60 | $6.40 |
| AVG Volume (30 Days) | 748.9K | ★ 8.6M |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,355,000.00 |
| Revenue This Year | N/A | $269.48 |
| Revenue Next Year | N/A | $262.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $1.60 |
| 52 Week High | $9.54 | $14.20 |
| Indicator | AURA | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.34 | 26.91 |
| Support Level | $6.65 | $1.60 |
| Resistance Level | $7.83 | $3.53 |
| Average True Range (ATR) | 0.41 | 0.35 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 60.05 | 6.20 |
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.